What the evidence says about Benzodiazepines for Anxiety

Benzodiazepines reduce acute anxiety quickly. Unlike SSRIs and SNRIs, which take weeks, benzodiazepines act within minutes to an hour. For short-term relief of severe anxiety or for occasional use, that speed is a genuine clinical benefit, and trials confirm short-term symptom reduction.

The concern is with longer-term use. With regular use the body develops tolerance, so the same dose produces less effect over time. Physical dependence can develop, and stopping after sustained use can cause a withdrawal syndrome. For this reason, clinical guidelines generally recommend benzodiazepines for short-term or situational use rather than as a long-term stand-alone treatment for an anxiety disorder.

The safety profile has been the subject of formal regulatory action. In 2020 the FDA required a class-wide update to benzodiazepine labeling to strengthen warnings about abuse, misuse, dependence, withdrawal, and the risks of stopping. Benzodiazepines also carry an FDA boxed warning about the danger of combining them with opioids, a combination that can cause severe sedation and slowed breathing.

For a patient-facing explainer you can share, PsychiatryRx's interactive guide lets readers watch what a benzodiazepine does in the brain, in plain language and without dosing advice.